The relationship between the presence of chromosomal instability and prognosis of squamous cell carcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from 47 Korean patients

Journal of Korean Medical Science

Volumn 25, Issue 6, 2010, Pages 863-867

  Yoo, Jung Wan ^a   Seo, Kwang Won ^a   Jang, Se Jin ^a   Oh, Yeon Mock ^a   Shim, Tae Sun ^a   Kim, Woo Sung ^a   Lee, Dong Soon ^b   Lee, Sang Do ^a   Choi, Chang Min ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Carcinoma; Chromosomal instability; Fluorescence; In situ hybridization; Lung neoplasms; Squamous cell

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN; PROTEIN C MYB;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CHROMOSOMAL INSTABILITY; CHROMOSOME 5; CHROMOSOME 6; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SMOKING; SOUTH KOREA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYB; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPUBLIC OF KOREA; SMOKING; SURVIVAL RATE;

EID: 77956401197     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.6.863     Document Type: Article

References (21)

1. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-30.
2. Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002; 21: 6884-97.
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
4. Nakamura H, Saji H, Idiris A Kawasaki N, Hosaka M, Ogata A, Saijo T, Kato H. Chromosomal Instability Detected by Fluorescence in Situ Hybridization in Surgical Specimens of Non-Small Cell Lung Cancer Is Associated with Poor Survival. Clin Cancer Res 2003; 9: 2294-9.
5. Kang JU, Koo SH, Kwon KC, Park JW, Shin SY, Kim JM, Jung SS. High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization. J Korean Med Sci 2007; 22 Suppl: S47-51.
6. Choi CM, Seo KW, Jang SJ, Oh YM, Shim TS, Kim WS, Lee DS, Lee SD. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients. Lung Cancer 2008; 64: 66-70.
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-7.
8. Stock C, Ambros IM, Lion T, Haas OA, Zoubek A, Gadner H, Ambros PF. Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer 1994; 11: 40-50.
9. Lee DY, Cho HI, Kang YH, Yun SS, Park SY, Lee YS, Kim Y, Lee DS. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies. Cancer Genet Cytogenet 2004; 152: 1-7.
10. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davis FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546-58.
11. Pirozynski M. 100 years of lung cancer. Respir Med 2006; 100: 2073-84.
12. Taguchi T, Zhou JY, Feder M, Litwin S, Klein-Szanto AJ, Testa JR. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosomespecific repetitive DNA probes. Cancer Genet Cytogenet 1996; 89: 120-5.
13. Mendelin J, Grayson M, Wallis T, Visscher DW. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest 1999; 79: 387-93.
14. Kwak KW, Kim SH, Lee HM. The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice. J Korean Med Sci 2009; 24: 1139-44.
15. Kim SR, Kim HJ, Kim SH. Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia. Korean J Lab Med 2009; 29: 371-8.
16. Yoon YS, Lee DS, Min HC, Jang JY, Lee SE, Hwang DW, Han HS, Kim SW. Analysis of molecular cytogenetics alteration of pancreatic cancer identified by fluorescent in situ hybridization (FISH) and its clinical significance. Korean J Hepatobiliary Pancreat Surg 2008; 12: 75-85.
17. Bubendorf L, Müller P, Joos L, Grilli B, Vogel S, Herzog M, Barascud A, Feichter G, Dalquen P, Tamm M. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 2005; 123: 516-23.
18. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006; 130: 694-701.
19. Jonsson S, Varella-Garcia M, Miller YE, Wolf HJ, Byers T, Braudrick S, Kiatsimkul P, Lewis M, Kennedy TC, Keith RL, Bjornsson J, McWilliams A, Lam S, Hirsch FR, Franklin WA. Chromosomal Aneusomy in Bronchial High-Grade Lesions Is Associated with Invasive Lung Cancer. Am J Respir Crit Care Med 2008; 177: 342-7.
20. Tseng RC, Hsieh FJ, Hsu HS, Wang YC. Minimal deletion regions in lung squamous cell carcinoma: Association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. Lung Cancer 2008; 59: 332-9.
21. Yakut T, Schulten HJ, Demir A, Frank D, Danner B, Egeli U, Gebitekin C, Kahler E, Gunawan B, Urer N, Oztürk H, Füzesi L. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer 2006; 54: 293-301.